MIG
MRNA icon

McGuire Investment Group’s Moderna MRNA Stock Holding History

McGuire Investment Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,235
Closed -$222K – 120
2022
Q4 		$222K Buy
+1,235
New +$202K 0.05% 105
2022
Q3 		– Sell
-1,556
Closed -$222K – 118
2022
Q2 		$222K Hold
1,556
– – 0.05% 108
2022
Q1 		$268K Sell
1,556
-142
-8% -$23.9K 0.05% 100
2021
Q4 		$431K Hold
1,698
– – 0.07% 86
2021
Q3 		$653K Hold
1,698
– – 0.12% 73
2021
Q2 		$399K Sell
1,698
-29
-2% -$5.18K 0.08% 87
2021
Q1 		$226K Buy
+1,727
New +$250K 0.05% 101

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

McGuire Investment Group's MRNA Position: Q1 2023 in Review

McGuire Investment Group sold out of Moderna (MRNA) in Q1 2023, closing a stake of 1,235 shares — an estimated $222K sold.

McGuire Investment Group first reported a position in MRNA in Q1 2021 and held it in 7 quarters. The position peaked at $653K in Q3 2021. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • McGuire Investment Group reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • McGuire Investment Group sold 1,235 Moderna shares in Q1 2023, an estimated $222K.
  • McGuire Investment Group first reported a position in Moderna in Q1 2021 and held it in 7 quarters.
  • McGuire Investment Group's Moderna position peaked at $653K in Q3 2021.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on McGuire Investment Group's 13F filing for Q1 2023, filed 20 Apr 2023.